Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV000987126 | SCV001136333 | uncertain significance | Biotinidase deficiency | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000998006 | SCV001153814 | uncertain significance | not provided | 2018-12-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000987126 | SCV003301955 | uncertain significance | Biotinidase deficiency | 2021-09-15 | criteria provided, single submitter | clinical testing | This sequence change replaces cysteine with phenylalanine at codon 33 of the BTD protein (p.Cys33Phe). The cysteine residue is weakly conserved and there is a large physicochemical difference between cysteine and phenylalanine. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the ExAC database. This missense change has been observed in individual(s) with biotinidase deficiency (PMID: 26117549). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The phenylalanine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |